Blog

2 August 2024 - A groundbreaking pan-tumour pharmaceutical that can act upon multiple different tumour types has been publicly funded ...

31 July 2024 - Australians fighting lung and liver cancer will soon be able to access a life-saving cancer treatment ...

1 August 2024 - The August 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

29 July 2024 - Australian children with cystic fibrosis now have access to cheaper medicines earlier under the PBS thanks ...

21 July 2024 - Australia’s medicine subsidy scheme is so crippled that a staggering 10,000 patients a year are being forced ...

19 July 2024 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the March 2024 ...

19 July 2024 - The utilisation analysis public release documents from the June 2024 DUSC meeting are now available. ...

19 July 2024 - The outcome statement from the June 2024 DUSC meeting is now available. ...

10 July 2024 - Australian children and young adults with neuroblastoma, a cancer that affects the nervous system, will be ...

10 July 2024 - The Health Technology Assessment (HTA) Policy and Methods Review concluded on 4 May 2024. The HTA ...

8 July 2024 - The post-market review workplan was considered by the PBAC at its intracycle meeting in May 2024. ...

5 July 2024 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the March 2024 PBAC ...

2 July 2024 - Australians with early breast cancer, leukaemia, and types of lupus, and insomnia, will now have access to ...

1 July 2024 - Version 5 of the agenda for the July 2024 PBAC meeting is now available; one major change. ...